Scientists at Northwestern Medicine have achieved a major advancement by using ultrasound technology to penetrate the blood-brain barrier and deliver chemotherapy and immunotherapies to treat glioblastoma, a deadly brain cancer.
In testing on glioblastoma patients and animal models, the treatment boosted the immune system’s recognition of cancer cells, potentially leading to a new therapeutic approach for this disease that afflicts 12,000 Americans annually.
